Stock Updates

Is AstraZeneca PLC(NYSE: AZN), a large market cap stock a smart buy?

With a market cap of has a large market cap size. AstraZeneca PLC (NYSE: AZN) has been on the stock market since its IPO date on the 5/17/1993. AstraZeneca PLC is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AstraZeneca PLC, is 4732.86, and so far today it has a volume of 4190081. Performance year to date since the 5/17/1993 is -7.86%.

To help you determine whether AstraZeneca PLC is undervalued the following values will help you decide. P/E is 26.23 and forward P/E is 13.47. PEG perhaps more useful shows that AstraZeneca PLC has a value for PEG of *TBA. P/S ratio is 3.09 and the P/B ratio is 5.2. The P/Cash and P/Free cash flow is 18.69 and *TBA respectively.

At the current price AstraZeneca PLC is trading at, 30.64 (1.12% today), AstraZeneca PLC has a dividend yield of 6.27%, and this is covered by a payout ratio of 121.20%. Earnings per share (EPS) is 1.16, and this is looking to grow in the next year to -4.50% after growing 128.90% this past year. EPS growth quarter over quarter is 17.50%, and 1.00% for sales growth quarter over quarter.

The number of shares outstanding is 2528, and the number of shares float is 2503.73. The senior management bring insider ownership to 0.50%, and institutional ownership is at 10.80%. The float short is 1.01%, with the short ratio at a value of 5.34. Management has seen a return on assets of 5.00%, and also a return on investment of 11.50%.

The ability for AstraZeneca PLC, to deal with debt, means it current ratio is 0.8, and quick ratio is 0.7. Long term debt/equity is 0.96 and total debt/equity is 1.11. In terms of margins, AstraZeneca PLC has a gross margin of 82.80%, with its operating margin at 17.00%, and AstraZeneca PLC has a profit margin of 11.80%.

The 52 week high is -9.31%, with 13.61% being its 52 week low. The 20 day simple moving average is 4.96% and the 200 day simple moving average is 1.69%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment